Systems/Biotech & Pharma

Deploy a Chief Technology Officer for your biotech or pharma company.

Bypass bloated consulting firms. Secure a US-based, Ivy League-educated CTO to navigate crossover or series c fundraise — entirely remotely, deployed in 48 hours.

48 hr
Avg. Deployment
100%
US-Based · Ivy League
14 day
No-Cause Cancellation
The Mandate

What Biotech & Pharma CEOs hire CTOs to solve.

  • 01Capital efficiency between trial milestones
  • 02Clinical, regulatory and commercial coordination
  • 03BD, licensing and pharma-partner negotiations
  • 04GxP, quality and supply chain readiness
Common Engagements

Where this CTO plugs in across Biotech & Pharma.

Crossover or Series C fundraise

Monolith decomposition or replatforming program

BD and licensing program

Engineering team scaling from 8 to 40 in 12 months

Commercial launch preparation

Post-incident reliability and security overhaul

Quality and compliance overhaul

Technical due diligence support for fundraising or M&A

Ready to DeployYour operator can be on the inside by Thursday.Choose a Tier
Deliverables

What lands in week one.

  • Architecture review with prioritized remediation backlog
  • Engineering org chart, leveling, and hiring plan
  • 12-month product and platform roadmap
  • Incident response runbooks and on-call rotation
KPIs Owned

The scoreboard they answer to.

  • ·Deploy frequency and change failure rate (DORA metrics)
  • ·P0/P1 incident count and mean time to recovery
  • ·Engineering velocity and cycle time
  • ·Infrastructure cost per active user

A Crimson Bench CTO converts technical uncertainty into an executive operating plan: architecture choices, engineering capacity, security posture, reliability, and product velocity all tied to commercial goals.

Still Evaluating?

Start with a $1,500 Executive Diagnostic — 2 hours, 3-page roadmap, refundable.

Live Bench